E.E. Geduld’s Marrone Bio Innovations, Inc. MBII Stock Holding History

E.E. Geduld’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-25,000	Closed	-$291K	–	286
2014 Q2	$291K	Buy	25,000 +10,000	+67%	+$113K	0.18%	136
2014 Q1	$210K	Sell	15,000 -5,000	-25%	-$78.5K	0.11%	177
2013 Q4	$356K	Buy	+20,000	New	+$325K	0.17%	136

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AWMDMG

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

OIM

Orca Investment Management Roseburg, Oregon $118M AUM 36.88% 1-Year Est. Return

E.E. Geduld's MBII Position: Q3 2014 in Review

E.E. Geduld sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2014, closing a stake of 25,000 shares — an estimated $291K sold.

E.E. Geduld first reported a position in MBII in Q4 2013 and held it in 3 quarters. The position peaked at $356K in Q4 2013. 49 funds tracked by Wall St. Rank hold MBII as of Q3 2014.

E.E. Geduld reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2014 after selling out during the quarter.
E.E. Geduld sold 25,000 Marrone Bio Innovations, Inc. shares in Q3 2014, an estimated $291K.
E.E. Geduld first reported a position in Marrone Bio Innovations, Inc. in Q4 2013 and held it in 3 quarters.
E.E. Geduld's Marrone Bio Innovations, Inc. position peaked at $356K in Q4 2013.
49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.